1. Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
   Yang Cheng et al, 2021, Frontiers in Oncology CrossRef
2. A Basic Survey on the Learning Needs of Nurses Caring for Patients with Intractable Cancer in Japan Based on Conceptual Education Integrating Oncology and Palliative Care
   Masako Nakamura et al, 2023, Journal of Cancer Education CrossRef
3. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas
   Liguo Ye et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
4. Identification of hub genes and pathways in hepatitis B virus‐associated hepatocellular carcinoma: A comprehensive in silico study
   Niloufar Sadat Kalaki et al, 2024, Health Science Reports CrossRef
5. KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy
   Xuchen Huang et al, 2023, International Journal of General Medicine CrossRef
6. Integrated Analysis of Transcriptome Data Revealed AURKA and KIF20A as Critical Genes in Medulloblastoma Progression
   Bo Liang et al, 2022, Frontiers in Oncology CrossRef
7. Overlaid Transcriptional and Proteome Analyses Identify Mitotic Kinesins as Important Targets of Arylsulfonamide-Mediated RBM39 Degradation
   Seemon Coomar et al, 2023, Molecular Cancer Research CrossRef
8. Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments
   Xiaoying Chang et al, 2021, Cancer Cell International CrossRef
9. KIF20A Promotes CRC Progression and the Warburg Effect through the C-Myc/HIF-1α Axis
   Min Wu et al, 2024, Protein & Peptide Letters CrossRef
10. Identification of potential biomarkers for pancreatic ductal adenocarcinoma: a bioinformatics analysis
    JagadeeswaraRao G et al, 2024, Computer Methods in Biomechanics and Biomedical Engineering CrossRef
11. Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
    Cristina Di Giorgio et al, 2023, Frontiers in Oncology CrossRef
12. Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer
    Regina Mbugua et al, 2024, International Journal of Oncology CrossRef
13. The Aurora B-controlled PP1/RepoMan complex determines the spatial and temporal distribution of mitotic H2B S6 phosphorylation
    Maximilian Pfisterer et al, 2024, Open Biology CrossRef
14. An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis
    Dongjie Sun et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
15. Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma
    Yang Yang et al, 2021, Frontiers in Immunology CrossRef
16. Inhibition of KIF20A suppresses the replication of influenza A virus by inhibiting viral entry
    Hoyeon Jeon et al, 2022, Journal of Microbiology CrossRef
17. Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches
    Paola Pastena et al, 2024, International Journal of Molecular Sciences CrossRef
18. Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers
    Y. Naeimzadeh et al, 2023, BioMed Research International CrossRef
19. Characterization of stem cell subtypes and prognostic signature in hepatocellular carcinoma
    Chenjie Qiu et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
20. The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor
    Valeria A. Copello et al, 2022, Oncogene CrossRef
21. Identification of key regulators associated with colon cancer prognosis and pathogenesis
    Narges Toolabi et al, 2022, Journal of Cell Communication and Signaling CrossRef
22. Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis
    Xian-Chang Zeng et al, 2020, Frontiers in Genetics CrossRef
23. Identifying Mitotic Kinesins as Potential Prognostic Biomarkers in Ovarian Cancer Using Bioinformatic Analyses
    Hailun Liu et al, 2022, Diagnostics CrossRef
24. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway
    Qi Wang et al, 2023, Drug Development Research CrossRef
25. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH
    Takuya Ogura et al, 2021, International Journal of Molecular Sciences CrossRef
26. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer
    Zheng Jin et al, 2023, Heliyon CrossRef